Brook et al., 2000 - Google Patents
Attempted endogenous tissue repair following experimental spinal cord injury in the rat: involvement of cell adhesion molecules L1 and NCAM?Brook et al., 2000
View PDF- Document ID
- 13290776864153565288
- Author
- Brook G
- Houweling D
- Gieling R
- Hermanns T
- Joosten E
- Bär D
- Gispen W
- Schmitt A
- Leprince P
- Noth J
- Nacimiento W
- Publication year
- Publication venue
- European Journal of Neuroscience
External Links
Snippet
It is widely accepted that the devastating consequences of spinal cord injury are due to the failure of lesioned CNS axons to regenerate. The current study of the spontaneous tissue repair processes following dorsal hemisection of the adult rat spinal cord demonstrates a …
- 208000008513 Spinal Cord Injury 0 title abstract description 22
Classifications
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by the preceding groups
- G01N33/48—Investigating or analysing materials by specific methods not covered by the preceding groups biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/5005—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells
- G01N33/5008—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics
- G01N33/502—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics for testing non-proliferative effects
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by the preceding groups
- G01N33/48—Investigating or analysing materials by specific methods not covered by the preceding groups biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
- G01N33/6872—Intracellular protein regulatory factors and their receptors, e.g. including ion channels
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- A61K38/18—Growth factors; Growth regulators
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
- A61K35/30—Nerves; Brain; Eyes; Corneal cells; Cerebrospinal fluid; Neuronal stem cells; Neuronal precursor cells; Glial cells; Oligodendrocytes; Schwann cells; Astroglia; Astrocytes; Choroid plexus; Spinal cord tissue
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICRO-ORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING OR MAINTAINING MICRO-ORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
- C12N5/06—Animal cells or tissues; Human cells or tissues ; Not used, see subgroups
- C12N5/0602—Vertebrate cells
- C12N5/0618—Cells of the nervous system
- C12N5/0623—Stem cells
Similar Documents
Publication | Publication Date | Title |
---|---|---|
Brook et al. | Attempted endogenous tissue repair following experimental spinal cord injury in the rat: involvement of cell adhesion molecules L1 and NCAM? | |
Ogata et al. | Structural and quantitative analysis of astrocytes in the mouse hippocampus | |
Menei et al. | Schwann cells genetically modified to secrete human BDNF promote enhanced axonal regrowth across transected adult rat spinal cord | |
Graeber et al. | The microglia/macrophage response in the neonatal rat facial nucleus following axotomy | |
Kajikawa et al. | Platelet‐rich plasma enhances the initial mobilization of circulation‐derived cells for tendon healing | |
Hiebert et al. | Brain‐derived neurotrophic factor applied to the motor cortex promotes sprouting of corticospinal fibers but not regeneration into a peripheral nerve transplant | |
Hampton et al. | A potential role for bone morphogenetic protein signalling in glial cell fate determination following adult central nervous system injury in vivo | |
Wang et al. | Localization of Nogo-A and Nogo-66 receptor proteins at sites of axon–myelin and synaptic contact | |
Stichel et al. | Inhibition of collagen IV deposition promotes regeneration of injured CNS axons | |
Joosten et al. | Collagen containing neonatal astrocytes stimulates regrowth of injured fibers and promotes modest locomotor recovery after spinal cord injury | |
Testen et al. | Region-specific reductions in morphometric properties and synaptic colocalization of astrocytes following cocaine self-administration and extinction | |
Becker et al. | Regenerating descending axons preferentially reroute to the gray matter in the presence of a general macrophage/microglial reaction caudal to a spinal transection in adult zebrafish | |
Mehanna et al. | Polysialic acid glycomimetics promote myelination and functional recovery after peripheral nerve injury in mice | |
Lee et al. | Motor recovery and anatomical evidence of axonal regrowth in spinal cord-repaired adult rats | |
Seitz et al. | Recovery from spinal cord injury: a new transection model in the C57Bl/6 mouse | |
Provenzano et al. | p75NTR and sortilin increase after facial nerve injury | |
Talaverón et al. | Implanted neural progenitor cells regulate glial reaction to brain injury and establish gap junctions with host glial cells | |
Martinian et al. | Calbindin D28K expression in relation to granule cell dispersion, mossy fibre sprouting and memory impairment in hippocampal sclerosis: a surgical and post mortem series | |
Zamecnik et al. | The extracellular matrix and diffusion barriers in focal cortical dysplasias | |
Mey et al. | Retinoic acid synthesis by a population of NG2‐positive cells in the injured spinal cord | |
Johnson et al. | Sodium channel subtypes are differentially localized to pre‐and post‐synaptic sites in rat hippocampus | |
DeFlitch et al. | Age and Alzheimer’s disease-related oligodendrocyte changes in hippocampal subregions | |
Lent et al. | Cellular and molecular tunnels surrounding the forebrain commissures of human fetuses | |
Goto et al. | Activation of 5-HT 4 receptors facilitates neurogenesis from transplanted neural stem cells in the anastomotic ileum | |
Willenberg et al. | Variable laterality of corticospinal tract axons that regenerate after spinal cord injury as a result of PTEN deletion or knock‐down |